Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.

A case-control study was carried out in Mexico City during 1995-1997 among women with epithelial ovarian cancer (84 cases) and endometrial cancer (85 cases). The control group consisted of 668 healthy women, matched according to age categories. In a multivariate analysis, the reproductive risk factors for ovarian and endometrial cancer are similar. The risk of ovarian cancer was inversely related to the number of full-term pregnancies; the odds ratio (OR) was 0.17 and the 95% confidence interval (CI) was 0.05-0.54 when comparing nulliparous women versus those with more than seven pregnancies. For endometrial cancer, a similar association was observed (OR, 0.11; 95% CI, 0.04-0.34). The use of oral contraceptive hormones was inversely associated with both ovarian (OR, 0.36; 95% CI, 0.15-0.83) and endometrial cancer risk (OR, 0.36; 95% CI, 0.14-0.90). In women with a history of more than 8.7 years without ovulation, the risk of ovarian cancer decreased four times (OR, 0.23; 95% CI, 0.10-0.50), and that of endometrial cancer decreased more than five times (OR, 0.17; 95% CI, 0.08-0.35). These two neoplasms are clearly typified as hormone dependent, and it is possible to establish that "ovulation" and "exfoliative" mechanisms jointly determine the level of risk for both ovarian and endometrial cancer.

Evaluation of the cervical cancer screening programme in Mexico: a population-based case-control study.

BACKGROUND: This study presents the evaluation of the Mexico City Cervical Cancer Screening Programme (CCSP). Uterine cervical cancer (CC) is still a major public health problem in Mexico. Various actions aimed at reducing mortality from CC have been unsuccessful with an estimated 62000 deaths reported between 1980 and 1995. METHODS: The authors performed a study of cases and controls chosen on a population basis that included a sample of 233 cases of cancer in situ, and 397 cases of invasive cervical cancer obtained from eight hospitals, and a sample of 1005 controls representative of the general population. The results are presented stratified by case type, classified according to whether the cancer is invasive or not. RESULTS: The results show low impact of the cervical cancer screening programme in Mexico. Women who had a history of use of the Papanicolaou smear (PAP), who did not seek testing due to gynaecological symptoms and who had received their PAP results, had a 2.63 times lower risk of developing invasive cervical cancer (OR = 0.38; 95% CI: 0.28-0.52). CONCLUSIONS: The principal findings of this study in relation to the low impact of the screening programme in Mexico, are the low level of existing coverage and late use of health services by women at risk.

Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico.

BACKGROUND: Mexico established a national cervical cancer-screening program in 1974. Despite the implementation of the program, there was a steady mortality trend of 16 per 100,000 women over 15 years. METHODS: A diagnostic procedure of the pitfalls was applied to the following steps of the screening procedure: Pap sampling quality; cytological diagnosis validity; compliance of women; and determinants of non-participation. RESULTS: The low effectiveness of screening on cervical cancer is principally due to factors associated with quality and coverage. Pap quality is deficient; 64% of a random sample of specimens lacked endocervical cells. Reading centers presented false negative indices of between 10 and 54%. Women seek screening in a late stage of disease (55% with cervical cancer seek care because they have symptoms). In addition, coverage is low; in women between 15 and 49 years of age in Mexico City, 64.2% have a history of Pap, compared with 30% in rural areas. Knowledge of what the Pap is used for strongly determines the use of screening. In rural areas, only 40% of women are informed about the purpose of the Pap test. CONCLUSIONS: A proposal to reorganize Mexico's screening program includes the following five main strategies: (a) increased coverage; (b) improved quality control of how cervical smears are taken; (c) better interpretation of Pap tests; (d) guaranteed treatment for those whose tests show abnormalities, and (e) improved follow-up.

Human papilloma virus 16-18 infection and cervical cancer in Mexico: a case-control study.

Cervical cancer (CC) is one of the principal public health problems in Mexico. The national mortality rate due to CC was estimated at 21.8 per 100,000 among women over 15 years old during 1994. Despite this high incidence little is known in Mexico about the risk factors for CC. The objectives of the study were to evaluate the association between CC and HPV types 16 and 18 in women living in Mexico City. From August, 1990 to December, 1992, a case-control study was carried out in the metropolitan area of Mexico City. HPV 16-18 types were determined in a sample of 148 CC cases and 204 controls randomly selected from a sample frame representative of the metropolitan area of Mexico City. Sixty cases corresponded to in situ CC and 88 cases to the invasive phase. Determination of HPV 16 and 18 types was done by polymerase chain reaction using primers specific to E6/E7. Results showed that 48.3% of in situ CC cases and 48.8% of invasive CC cases were positive for HPV 16 while only 13.2% were positive among the 204 controls. Association between HPV 16 infection in the in situ cancer cases had an estimated odds ratio (OR) of 5.17 (95% CI 2.60-10.51). In the invasive cervical cancer cases, association between HPV 16 infection and invasive CC in this sample had an OR of 3.84 (95% CI 2.04-7.22). For the total sample, the estimated OR was 5.48 (95% CI 3.07-9.62). In the total sample, those women with a strong positive reaction to PCR were associated with a large increase in the risk, OR of 38.0 (95% CI 8.66-167.1). The prevalence the HPV 18 was 6.7%, only observed in the invasive cervical cancer cases. At present there is general consensus that HPV is the principal causal agent in C C etiology. This study intends to contribute to the knowledge concerning the etiology of cervical cancer. However, it is necessary to consider that the single most effective tool in the reduction of mortality due to cervical cancer has been the Pap test. Secondary prevention has proven to be highly effective in other populations, and this should be viewed as a priority activity for all at-risk populations. Although a vaccine for HPV may be available in the near future its efficacy in primary prevention has yet to be demonstrated.

Trends of lung cancer mortality in Mexico.

Lung cancer (LC) is one of the most important public health problems in the world; 1,035,000 annual deaths are estimated each year and more than 80% of these are attributed to tobacco. The trend of lung cancer mortality in Mexico City from 1979 - 1993 was determined, as was the rate ratio of lung cancer mortality in 31 states in Mexico, taking Mexico City as a reference by means of a Poisson model. A strong linear regression model was used to evaluate the rate, where the dependent variable was LC mortality rate and the independent variable the year observed. In 15 years, 73,807 deaths from LC were reported, with an increase in mortality from 5.01 - 7.25 per 100,000 inhabitants. Mortality increases significantly after 60 years of age (B not equal to 0), p<.05) in men and in women. Mortality from LC was 70% in men, and more than 60% of deaths were reported after 65 years of age. Mortality risk is higher in the northern states of the country (e.g., Sonora, RR=2.40) than in the southern region (e.g., Oaxaca RR=0.40). In Mexico, almost 10,000 deaths by LC are estimated for the year 2010. Therefore, changes in lifestyle should be encouraged in order to decrease the smoking habit. The governmental tax on cigarettes should be increased, smoking restricted in squares and public spaces, and the risks should be announced on cigarette packages, among other measures. With respect to other emergent risk factors, the sources of industrial pollution and toxic emissions should be regulated.

Conservative surgery for ovarian cancer and effect on fertility.

OBJECTIVE: A survey that compared two alternatives (conservative and radical surgery) is presented on ovarian cancer treatment evaluating its effect on progression-free survival and fertility, in a 10-year time period, in Mexican women. METHODS: 72 women between 11 and 58 years old with unilateral ovarian cancer in different stages were studied. Several methods were analyzed: (1) progression-free survival, using Mantel and Haenzsel test to compare in terms of life curves and the Kaplan-Meier method. The exposure variable was surgery type, using the Mantel-Cox test to evaluate the difference in life curves by clinical stages and by surgery type; (2) fertility was evaluated in women who received conservative surgery, considering the cumulative pregnancy rate in women successfully pregnant after surgical and/or adjuvant treatment. RESULTS: There were no difference in survival curves when evaluating progression-free survival, in either group (Z = 1.09 and Pr > (z) = 0.27). During the study period, we found that 87.5% of patients were alive with no evidence of disease. There were no differences in survival curves when evaluating progression-free survival according to surgery type and clinical stage (chi 2 = 0.66, P = 0.88). Restart of menstruation in patients with conservative surgery occurred before 6 months in 89% of the sample, 22 women with possible parity had a 59.1% cumulative pregnancy rate. CONCLUSION: The outcomes from this survey carried out in Mexico show that conservative treatment of ovarian cancer in early clinical stages is an efficient alternative to preserve reproductive function in young women, and does not show differences in progression-free survival compared to radical surgery.

Age of natural menopause among women in Mexico City.

OBJECTIVES: The average age of menopause among women in Mexico City was calculated, considering their reproductive and socio-demographic characteristics. The information was obtained from a population-based control group from a case-controlled study of gynecologic cancer. METHODS: Interviews were carried out with 1005 women resident in Mexico City chosen at random from a sample using the housing sample framework of the Mexico General Directorate of Epidemiology, 472 of whom had undergone a natural menopause. RESULTS: The most important results include an average age for menopause in this population of 46.5 +/- 5 years (95% C.I. 46-48) with a median of 47. Groups of women with an average early menopause were those with no formal education (1.6 years), low socio-economic level (1.3 years, P < 0.05), nulliparas (2.6 years, P < 0.05), those who had never breastfed (2.2 years, P < 0.05) and those who had not used contraceptive hormones (1.7 years, P < 0.05). CONCLUSION: This phenomenon must be documented in Mexico because of its strong links with the morbidity and mortality of the growing number of women who are reaching advanced ages and whose survival is calculated at 30 years after menopause.

Reproducibility study of cervical cytopathology in Mexico: a need for regulation and professional accreditation.

Due to the high rate of false negative results in diagnosis of cervical cytopathology, in many countries its practice has been transformed through the application of several interventions aimed at medical regulation to improve diagnostic accuracy. Diagnostic reproducibility of gynecological cytopathology was evaluated in a series of 20 cytology specimens [Papanicolaou (Pap)] and 20 cervical biopsy. (CB) studies in different clinical stages, during 1994. The observation unit consisted of 30 pathologists who observed 2 groups of 20 Pap and 20 CB specimens. The standard was a cytopathologist certified by the Pathological Anatomy Council of Mexico. Intraclass reproducibility in gynecological cytopathology is low in Mexico. In a group analysis, concordance increased as clinical status of the cervical lesion increased. For moderate dysplasia, concordance in Pap was kappa = 0.04, compared to 0.23 in CB. Concordance of diagnosis of invasive cancer was 0.29 for Pap and 0.64 for CB. Using weighted kappa at the individual level for all possible diagnoses, concordance varied from 0.29 to 0.59 for Pap, and 0.42 to 0.65 for CB. The problem of reproducibility in cervical cytopathology in Mexico emphasizes the need for continuing education, uniform diagnostic criteria, and the advantages of a single operational classification-possibly the Bethesda System-since current classification systems are obsolete.

Quality control study on negative gynecological cytology in Mexico.

An external evaluation of the quality of diagnosis of gynecological cytology specimens (Papanicolaou or "Pap" tests) in the Cytopathological Laboratory at the Mexico General Hospital was performed, with evaluation of 6,011 Pap tests randomly selected from 31,378 Pap studies previously reported as negative during 1988-1989. These tests were part of the early detection program for cervical cancer run by the Ministry of Health of Mexico City. A quality index for specimens was constructed based on the presence of endocervical cells, mucus, and squamous metaplastic cells. The index of false negatives for the diagnosis of cervical neoplasm in this sample which correspond to diagnostic error by the examiner was 0.18% (11). The constructed quality index revealed that 64.1% of specimens were low quality. The correlation between diagnostic error and low quality was .87. Results indicate that laboratories participating in early detection programs for cervical cancer in developing countries need to implement (1) external evaluation programs for Pap diagnosis; (2) permanent training programs in registration; and (3) monitoring procedures for collection, fixation, and transportation of cytologic materials.

Mortality from cervical carcinoma in Mexico: impact of screening, 1980-1990.

OBJECTIVE: To determine the temporal mortality trends of uterine cervical cancer in Mexico for the period 1980-1990. STUDY DESIGN: In Mexico, data from death certificates are collected in a national repository at the National Institute of Statistics, Geography and Informatics. These data were analyzed to obtain mortality trends, and regional variations were obtained for the same period using a Poisson regression model. RESULTS: The official mortality figure for cervical cancer for the study period was 37,982 cases. Subregistration due to misclassification was evident, particularly in the first five years of the study period; however, poor quality of information was proportionally distributed across the different age groups. A standardized analysis by quinquennia showed a steady mortality trend during the last 10 years, with slightly upward significant trends within some age groups (beta=0, P<.05). High regional variations in cervical cancer mortality risks were found using a Poisson regression model. Twenty-four states in Mexico showed an increased mortality risk when compared with Mexico City; seven states showed a steady or downward trend. CONCLUSION: The results show the ineffectiveness of the cancer screening program, underscoring the need to ensure access to and the quality of the cervical cancer screening program in order to decrease mortality rates.

Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico.

OBJECTIVE: To evaluate the diagnostic precision of the cervical cytology (smear) in a sample of 16 cervical cancer screening centers (CCSCs) from the Mexican Ministry of Health and Mexican Institute for Social Security CCSCs distributed across the country. STUDY DESIGN: Each center received a batch of 90 cytologic specimens with a random positive prevalence of 1.5-36%. Positive cases were always histologically confirmed. The "gold standard" was an expert pathologist certified by the Mexican Board of Pathology. RESULTS: Our results show that cytologic diagnosis validity and reproducibility vary greatly within and between institutions. The false negative rate (FNR) varied between 10% and 54%, independent of the prevalence of positive cases. CONCLUSION: Quality control of diagnostic precision is central to the consistency of results obtained at CCSCs. In Mexico the high FNR calls for governmental regulation of cytopathology policies and methods, such as through national and international accreditation of cytotechnology programs. In order to decrease the FNR, developing countries must frame managerial development strategies to streamline the cervical cancer screening program, including continuing education, improvement of operation processes in CCSCs, internal and external quality control of cytopathology laboratories and cervical sampling procedures, and standardization of diagnostic criteria.

[Diagnostic concordance in gynecologic cytology]. / Concordancia diagnóstica en citología ginecológica.

OBJECTIVE: To evaluate the diagnostic agreement in Papanicolaou of pathologists and cytotechnologists using kappa values for concordancy. METHODS: The diagnostic variation was estimated in 20 gynecological cytology (Pap) specimens by 30 pathologists and 7 cytotechnologists attending the XXXVII Congress of the Mexican Association of Pathologists in 1994. RESULTS: The best concordancy versus an expert was in tumoral diathesis (pathologists' kappa = 0.36; cytotechnologists' kappa = 0.35) and kollocytos (pathologists' kappa = 0.55; cytotechnologists' kappa = 0.36). The least concordancy was observed in anisonucleosis (pathologists' kappa = 0.11; cytotechnologists' kappa = 0.02), nuclear hyperchromasia (pathologists' and cytotechnologists' kappa = 0.11) and dyskeratosis (pathologists' kappa = 0.11; cytotechnologists' kappa = 0.16). The kappa values for cervical neoplasia showed poor agreement, and in invasive cervical cancer it was 0.30. CONCLUSIONS: There was a low concordancy of Pap diagnosis in the study. It is convenient to try to improve the concordancy of cytologic diagnosis in Mexico. One strategy could be the use of a uniform diagnostic criteria and the adoption of a single nomenclature.

[Reproductive risk factors and sexual history associated with cervical cancer in Mexico]. / Factores de riesgo reproductivo e historia de vida sexual asociados a cáncer cervical en México.

Uterine cervical cancer is one of the principal public health problems in Mexico. The national mortality rate for cervical cancer in 1991 is estimated at 9.5 per 100,000 women, representing 4,194 deaths. In the period from August 1990 to December 1992, a case-control study was carried out that included 630 cases of histologically confirmed cervical cancer in eight Mexico City hospitals (two for people with no social security cover, four of the social security system and two private). As controls, 1,005 women were chosen from a random sampling of houses in the Mexico City metropolitan area. The main cervical cancer risk factors found in this study, adjusted for a multivariate model, were multiple normals births (with five births OR of 1.93 and 95% C.I. of 1.22-2.73) and a history of two or more sex partners (the OR with four or more sex partners was 5.56 and a C.I. of 2.3-13.4). In addition, there was an estimated lower risk of disease related to starting a sex life after 25 years of age (OR 0.41 with C.I. of 0.25-0.69) and to having cesareans as compared versus one normal birth (OR 0.28 and C.I. of 0.13-0.61). The information obtained is relevant since it identifies Mexican women with a high-risk of developing cervical cancer which can be used in planning programs for the early detection of cancer in this population.

[Cancer of the uterine cervix. Historical perspective]. / Cáncer de cuello uterino. Una perspectiva histórica.

This paper describes the existing etiological paradigms which explain the development of cervical cancer (CACU), and particular, is a review of the historical attempts to explain the occurrence of the disease. Previous analysis concerning the prevalence of CACU in populations has been based on empirical work which can be summarized in several public health models, including: biomedical, hygienist-preventive, epidemiologic, ecologic, and social medical. We conclude that the existing paradigms must be reoriented in order to formulate organized social responses for the control of CACU.

[Evaluation of a program for the early detection of cancer of the uterine cervix in Mexico City. A populational-based epidemiologic study of cases and controls]. / Evaluación del programa de detección oportuna del cáncer del cuello uterino en la Ciudad de México. Un estudio epidemiológico de casos y controles con base poblacional.

Cervical cancer is still an important public health problem in Mexico; in spite of the development of various programs aimed at lowering mortality due to this disease, impact has not yet been achieved. In this study we present an evaluation of the Early Detection Program for Cervical Cancer in Mexico City. The authors carried out a case-control study with a populational base, in which a sample of cases obtained in eight hospitals and a sample of controls representative of the general population were included. We report a protective effect attributed to the program. The women with complete cytology showed 2.4 times less risk of cervical cancer. Nevertheless the effect of the program at a populational level is still limited because it covers only 20 per cent of the cases in the population. The results indicate the need for developing operative research programs in order to increase the demand for and the quality and efficiency of preventive services.

[Epidemiology of cancer of the breast in Mexico. Consequences of demography transition]. / La epidemia de cáncer de mama en México. Consecuencia de la transición demográfica?

OBJECTIVE: Analyze the relation between reductions in fertility and the inverse en breast cancer mortality in the different states of Mexico for the period 1979-1994. MATERIALS AND METHODS: Fertility rates and beast cancer mortality rates were utilized to analyze the proposed relationship in the states of the country. Principal component analysis and classification analysis were then used in the confirmatory analysis of this relationship. RESULTS: There is an important decrease in fertility trends overall with regional differences: the northern states of Mexico have lowest then the southern states. These regional differences are inversely related to the observed differences in breast cancer mortality within the states: the northern states have levels of breast cancer mortality much higher than the southern states. CONCLUSIONS: The increase in mortality due to breast cancer and its relation to the decrease in fertility illustrates the importance that must be given to the preventive aspect of health services since in the near future Mexican women will exhibit reproductive behaviors similar to women in developed countries.

[Epidemiologic panorama of cancer mortality in the Mexican Institute of Social Security: 1991-1995]. / Panorama epidemiológico de la mortalidad por cáncer en el Instituto Mexicano del Seguro Social: 1991-1995.

OBJECTIVE: This paper describes the global cancer mortality and the specific mortality patterns for the main neoplasms among adult members of the Mexican Institute of Social Security (IMSS). MATERIAL AND METHODS: Using official death certificates and information about the population of the IMSS members during 1991-1995, national and regional annual global cancer mortality as well as specific mortality rates for the 10 most important malignant neoplasms by sex were estimated among people older than 20 years of age. The trends for these neoplasms during the study period were estimated by means of Poisson regression. The rate differences in specific cancer mortality by region and sex, for the two major neoplasms, were calculated subtracting specific regional rates from the respective national rate in 1995. RESULTS: The global mortality rate for cancer among men increased from 76.2 in 1991 to 94.8 x 100000 IMSS' members in 1995; and among women from 85.6 to 105.8 x 100000 IMSS' members, representing an increment of 24.4 and 24% men and women, respectively, during the study period. Among men, neoplasm of kidney, leukemia, pancreas, prostate and lung showed the major increment; among women, neoplasm of colon, breast, pancreas, leukemia and liver showed the most significant increment. CONCLUSIONS: In the IMSS it is necessary the integration of a population based cancer registry. The registry will play a main role in disease surveillance and control; will give basic information over incidence and temporal variation, and could be the main source of information for epidemiologic research, as well as planning and evaluation of the quality of medical attention services such as prevention and early diagnosis and treatment.

Prostate cancer mortality trends in Mexico, 1980-1995.

BACKGROUND: In Mexico, prostate cancer (PC) is the second highest cause of mortality by cancer in men. In 1991, there were 2,473 deaths, with a crude rate of 5.66 cases per 100,000 men age 40 or over. For this same year, the ratio of proportional mortality to the total number of malignant tumors was 12.6%. Our objectives were to determine the trends and geographic distribution of mortality for PC in Mexico for 1980-1995. METHODS: Crude and adjusted mortality rates were carried out for 1980-1995. A test for trend was done using the simple lineal regression method. The standardized mortality ratio (SMR) was calculated for 1980-1995 for each Mexican state. RESULTS: The total number of deaths by PC in Mexico for 1980-1995 was 32,349. The crude mortality rate increased during that period from 3.16 to 6.75 cases per 100,000 men over age 40. The statistical trend test with respect to time was significant (P<0.0001). The state of Southern Baja California showed a higher SMR, and a smaller SMR was shown for the state of Quintana Roo. CONCLUSIONS: The mortality trends for PC increased for the period studied. It represents a serious problem for public health. We find that the central and northern states of the country, characterized by a greater industrial and socioeconomic development, are those with a higher SMR.

Epidemiologic panorama of colorectal cancer in Mexico, 1980-1993.

INTRODUCTION: Colorectal cancer is the third cause of cancer-related death in the world, with 468,000 estimated deaths in 1993. In some countries mortality rates have started to decline, and survival rates have increased. In this study performed in Mexico, information is presented on the increase in mortality from this form of cancer, especially in more economically developed areas. METHODS: The mortality trend for colorectal cancer was evaluated and standardized by five-year age groups in the period 1980 to 1993. Also, the standardized mortality ratio was calculated for Mexico's 32 states, as was the possible association between mortality and indicators of rurality level and fertility rates in the different regions of Mexico. RESULTS: In the period studied, 18,962 deaths were officially reported. The average age of death was 66 years. The mortality rate among women (1.8) was significantly higher than among men (1.55 per 100,000 inhabitants). Mortality from colorectal cancer grew by 100 percent in both genders (beta = 0.089; P < 0.001), especially in the age group 34 and younger, in the 45 to 49 age group, and in the older than 75 age group (P < 0.05). The standardized mortality ratio was greater in the states in the north of Mexico. Finally, an inverse correlation was observed throughout Mexico between the rurality index (r = -0.60; P < 0.001) and the fertility rates (r = -0.43; P < 0.05) and mortality from colorectal cancer. CONCLUSIONS: In this study, there is evidence that mortality from this cancer is higher in geographic areas with greater socioeconomic development, similar to regional patterns observed in other countries. In Mexico, the coming years will see a serious epidemic in mortality from this disease; therefore, immediate attention must be given to identifying the profile of high-risk subjects and implementing early cancer detection measures.

[Reproductive risk factors and uterine cervix cancer in Mexico City]. / Factores de riesgo reproductivo y cáncer cérvico-uterino en la Ciudad de México.

An epidemiological case control study nested in the Early Cancer Detection program of the Health Ministry in Mexico City was carried out to evaluate the principal reproductive risk factors associated with uterine cervix cancer. Information from 12,741 gynecological cytologies reported to the National Cancer Registry, during the period between January 2 to March 31, 1987 was studied. In this population group the most important reproductive risk factors associated with uterine cervix cancer were: multiple births (seven or more births, OR = 3.24, IC 95% = 2.20-4.76), initiation of active sex life before 14 years (OR = 1.53, 95% IC = 1.13-2.08) and late menarche (in the group with menarche after 17 year of ages OR = 3.22, 95% IC = 1.06-9.77). In relation to the Early Cancer Detection program, an important number of women made use of the program when they showed symptoms. The prevalence among women who had at least one symptom was 43.09 per cent. Women with a tumor at the cervical level at the time of the cytology were 7.76 times more likely to have of uterine cervix cancer (95% IC = 4.84-13.15). Symptoms such as dysfunctional bleeding (OR 2.79, IC 95% = 1.90-4.12), metrorrhagia (OR 2.66, 95% IC 1.83-3.86) and bloody leukorrhea (OR 2.64, 95% IC 2.05-3.38) can be relevant findings in women at high risk. The attributable fraction of higher exposure in the presence of gynecological signs and symptoms is the cervical tumor, with 87.46 per cent.(ABSTRACT TRUNCATED AT 250 WORDS)